1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Demographics and clinical information
RN (n = 20 Lesions) Tumor (n = 17 Lesions) Age (mean) (SD) (yr)a 65 (8.9) 54 (12.8) Sex (male/female)a 9:8 3:10 Primary tumorb Lung 10 (50.0%) 3 (17.6%) Breast 5 (25.0%) 9 (52.9%) Melanoma 2 (10.0%) 0 Colorectal 2 (10.0%) 0 Tonsillar 1 (5.0%) 0 Sinonasal 0 3 (17.6%) Ovarian 0 2 (11.8%) Surgical resection for determination of histopathologic ground truth diagnosisb 7 (35.0%) 6 (35.2%) Interval time between end of radiation and first MR imaging (median) (range) (mo) 24.9 (4–109) 16.3 (3–41) Interval time between end of radiation and PET-MR imaging (median) (range) (mo)c 27.9 (14–117) 12.4 (6–37) Total radiation dosage (mean) (SD) (Gy) 24.5 (4.2) 22.8 (3.1)
↵a Thirty subjects who had a total of 37 lesions (n = 20 RN; n = 17 tumor) were included in age and sex analyses.
↵b Percentages for primary tumor type and surgical resection are relative to the total number of lesions within each column.
↵c Subset of 17 subjects who had a total of 20 lesions (n = 8 RN, n = 12 tumor) who underwent PET-MRI.